At a glance
This grant funds research on early immune system development in neonates, infants, children, and adolescents, especially in the context of HIV, anti-retroviral exposure, maternal and paternal immune status, and related factors such as the microbiome, co-infections, diet, metabolism, and obesity. Eligible applicants include a wide range of U.S. and non-U.S. organizations, including nonprofits, universities, governments, for-profit organizations, and foreign organizations. Application budgets are limited to $400,000 per year in direct costs, excluding consortium F&A costs, and the project period can be up to four years. No cost sharing is required, and foreign components and non-domestic entities are allowed.
What it funds
Official description from grants.gov
The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.
Who can apply
- City or township governments
- County governments
- For-profit organizations other than small businesses
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Others
- Private institutions of higher education
- Public and State controlled institutions of higher education
- Public housing authorities / Indian housing authorities
- Small businesses
- Special district governments
- State governments